{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:03:15Z","timestamp":1774944195472,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aims at describing the imaging features of the metastatic presentation of clear cell renal cell carcinoma (ccRCC) in arterial (AP) and portal venous phase (PVP) of contrast-enhanced-computed-tomography (CECT) during clinical follow-up (FU) and to evaluate the necessity of a dual phase approach for metastasis detection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We identified a total of 584 patients that were diagnosed with ccRCC between January 2016 and April 2020. Inclusion criteria were histologically proven ccRCC with metastatic spread, proven by histology or interim follow-up of at least 2 years and follow-up CT examination with AP and PVP CECT including thorax\/abdomen and pelvis. Exclusion criteria were defined by missing or incomplete CT-scans or lack of sufficient follow-up. CT studies of 43 patients with histologically proven ccRCCs were analyzed in retrospect. AP and PVP images were analyzed by two radiologists for metastases, two additional independent radiologists analyzed PVP images only. A 5-point Likert scale was used to evaluate the likelihood off the presence of metastasis. Imaging patterns of the metastases were analyzed visually.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>43 patients (16 female; mean age: 67\u00b110 years) with recurrent ccRCC and metastatic disease were included. Three imaging patterns were observed (solid, heterogeneous or cystic metastases), which rarely exhibited calcifications (2%). All metastases showed hyperenhancement in AP and PVP. Inter-reader agreement was substantial (Fleiss\u2019 \u03ba 0.6\u20130.8, <jats:italic>p<\/jats:italic>&lt;0.001). No significant differences in sensitivity or specificity between readers (AP and PVP images vs. PVP images only) were present (79.4-85.2%, 97.1-99.6%, p \u2265 0.05). The area under the receiver-operating-characteristic (ROC) curve was between 0.901and 0.922 for all four radiologists.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Similar rates for detection, sensitivity and specificity of metastasis and local recurrence in ccRCC were observed irrespective of using a dual-phase protocol with AP and PVP or a single PVP protocol only. Thus, a single-phase examination of PVP can be sufficient for experienced radiologists to detect metastatic disease in the follow-up of ccRCC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-022-00444-8","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:03:22Z","timestamp":1642759402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? \u2013 a single-center retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Florian","family":"Hagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Peisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Spogis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Mair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang M.","family":"Thaiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"6","key":"444_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374\u2013403. https:\/\/doi.org\/10.1016\/j.ejca.2012.12.027.","journal-title":"Eur J Cancer"},{"key":"444_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.005","author":"J Bedke","year":"2020","unstructured":"Bedke J, Albiges L, Capitanio U, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-na\u00efve Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol. 2020. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.005.","journal-title":"Eur Urol"},{"issue":"2","key":"444_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.juro.2007.09.036","volume":"179","author":"NE Hoffmann","year":"2008","unstructured":"Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol. 2008;179(2):474\u20137. https:\/\/doi.org\/10.1016\/j.juro.2007.09.036.","journal-title":"J Urol"},{"issue":"2","key":"444_CR4","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.clgc.2018.07.024","volume":"17","author":"C Vogel","year":"2019","unstructured":"Vogel C, Ziegelm\u00fcller B, Ljungberg B, et al. Imaging in Suspected Renal-Cell Carcinoma: Systematic Review. Clin Genitourin Cancer. 2019;17(2):e345\u201355. https:\/\/doi.org\/10.1016\/j.clgc.2018.07.024.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"444_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol. 2019;75(5):799\u2013810. doi:https:\/\/doi.org\/10.1016\/j.eururo.2019.02.011.","journal-title":"Eur Urol"},{"issue":"10","key":"444_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11934-018-0830-z","volume":"19","author":"CW Liaw","year":"2018","unstructured":"Liaw CW, Winoker JS, Mehrazin R. Imaging Protocols for Active Surveillance in Renal Cell Carcinoma. Curr Urol Rep. 2018;19(10):81. https:\/\/doi.org\/10.1007\/s11934-018-0830-z.","journal-title":"Curr Urol Rep"},{"issue":"5","key":"444_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.rcl.2020.05.003","volume":"58","author":"JS Chu","year":"2020","unstructured":"Chu JS, Wang ZJ. Protocol Optimization for Renal Mass Detection and Characterization. Radiol Clin North Am. 2020;58(5):851\u201373. https:\/\/doi.org\/10.1016\/j.rcl.2020.05.003.","journal-title":"Radiol Clin North Am"},{"key":"444_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejrad.2018.05.002","volume":"107","author":"O Ali","year":"2018","unstructured":"Ali O, Fishman EK, Kawamoto S. Recurrent renal cell carcinoma following nephrectomy and ablation therapy: Radiology perspective. Eur J Radiol. 2018;107:134\u201342. https:\/\/doi.org\/10.1016\/j.ejrad.2018.05.002.","journal-title":"Eur J Radiol"},{"issue":"12","key":"444_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00345-018-2338-z","volume":"36","author":"S Dabestani","year":"2018","unstructured":"Dabestani S, Marconi L, Kuusk T, Bex A. Follow-up after curative treatment of localised renal cell carcinoma. World J Urol. 2018;36(12):1953\u20139. https:\/\/doi.org\/10.1007\/s00345-018-2338-z.","journal-title":"World J Urol"},{"issue":"1","key":"444_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1148\/radiol.2341031733","volume":"234","author":"EJ Chae","year":"2005","unstructured":"Chae EJ, Kim JK, Kim SH, Bae S-J, Cho K-S. Renal cell carcinoma: Analysis of postoperative recurrence patterns. Radiology. 2005;234(1):189\u201396. https:\/\/doi.org\/10.1148\/radiol.2341031733.","journal-title":"Radiology"},{"issue":"3","key":"444_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1258\/ar.2012.120693","volume":"54","author":"MT Corwin","year":"2013","unstructured":"Corwin MT, Lamba R, Wilson M, McGahan JP. Renal cell carcinoma metastases to the pancreas: Value of arterial phase imaging at MDCT. Acta Radiol. 2013;54(3):349\u201354. https:\/\/doi.org\/10.1258\/ar.2012.120693.","journal-title":"Acta Radiol"},{"issue":"11","key":"444_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.crad.2011.06.002","volume":"66","author":"Y Jain","year":"2011","unstructured":"Jain Y, Liew S, Taylor MB, Bonington SC. Is dual-phase abdominal CT necessary for the optimal detection of metastases from renal cell carcinoma? Clin Radiol. 2011;66(11):1055\u20139. https:\/\/doi.org\/10.1016\/j.crad.2011.06.002.","journal-title":"Clin Radiol"},{"issue":"11","key":"444_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4329\/wjr.v5.i11.436","volume":"5","author":"SF Coquia","year":"2013","unstructured":"Coquia SF, Johnson PT, Ahmed S, Fishman EK. MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence. World J Radiol. 2013;5(11):436\u201345. https:\/\/doi.org\/10.4329\/wjr.v5.i11.436.","journal-title":"World J Radiol"},{"issue":"2","key":"444_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2214\/AJR.07.2077","volume":"189","author":"N Griffin","year":"2007","unstructured":"Griffin N, Gore ME, Sohaib SA. Imaging in metastatic renal cell carcinoma. AJR Am J Roentgenol. 2007;189(2):360\u201370. https:\/\/doi.org\/10.2214\/AJR.07.2077.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"444_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13244-021-00980-0","volume":"12","author":"D Caruso","year":"2021","unstructured":"Caruso D, Rosati E, Panvini N, et al. Optimization of contrast medium volume for abdominal CT in oncologic patients: prospective comparison between fixed and lean body weight-adapted dosing protocols. Insights Imaging. 2021;12(1):40. https:\/\/doi.org\/10.1186\/s13244-021-00980-0.","journal-title":"Insights Imaging"},{"issue":"9","key":"444_CR16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00330-004-2321-5","volume":"14","author":"S Itoh","year":"2004","unstructured":"Itoh S, Ikeda M, Achiwa M, Satake H, Iwano S, Ishigaki T. Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: automatic bolus tracking or empirical scan delay? Eur Radiol. 2004;14(9):1665\u201373. https:\/\/doi.org\/10.1007\/s00330-004-2321-5.","journal-title":"Eur Radiol"},{"issue":"1","key":"444_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiology.211.1.r99ap4187","volume":"211","author":"BA Birnbaum","year":"1999","unstructured":"Birnbaum BA, Jacobs JE, Langlotz CP, Ramchandani P. Assessment of a bolus-tracking technique in helical renal CT to optimize nephrographic phase imaging. Radiology. 1999;211(1):87\u201394. https:\/\/doi.org\/10.1148\/radiology.211.1.r99ap4187.","journal-title":"Radiology"},{"issue":"1","key":"444_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"3","key":"444_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2214\/AJR.19.21681","volume":"214","author":"M Tordjman","year":"2020","unstructured":"Tordjman M, Dbjay J, Chamouni A, et al. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns. AJR Am J Roentgenol. 2020;214(3):579\u201387. https:\/\/doi.org\/10.2214\/AJR.19.21681.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"444_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00261-008-9391-9","volume":"34","author":"S Mech\u00f3","year":"2009","unstructured":"Mech\u00f3 S, Quiroga S, Cu\u00e9llar H, Sebasti\u00e0 C. Pancreatic metastasis of renal cell carcinoma: Multidetector CT findings. Abdom Imaging. 2009;34(3):385\u20139. https:\/\/doi.org\/10.1007\/s00261-008-9391-9.","journal-title":"Abdom Imaging"},{"issue":"1","key":"444_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/cbt.9.1.10340","volume":"9","author":"PD Nathan","year":"2010","unstructured":"Nathan PD, Vinayan A, Stott D, Juttla J, Goh V. CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies. Cancer Biol Ther. 2010;9(1):15\u20139. https:\/\/doi.org\/10.4161\/cbt.9.1.10340.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"444_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2214\/ajr.180.5.1801217","volume":"180","author":"IR Francis","year":"2003","unstructured":"Francis IR, Cohan RH, McNulty NJ, et al. Multidetector CT of the liver and hepatic neoplasms: Effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003;180(5):1217\u201324. https:\/\/doi.org\/10.2214\/ajr.180.5.1801217.","journal-title":"AJR Am J Roentgenol"},{"key":"444_CR23","doi-asserted-by":"publisher","unstructured":"Caruso D, Cecco CN de, Schoepf UJ, et al. Can dual-energy computed tomography improve visualization of hypoenhancing liver lesions in portal venous phase? Assessment of advanced image-based virtual monoenergetic images. Clin Imaging. 2017;41:118\u201324. https:\/\/doi.org\/10.1016\/j.clinimag.2016.10.015.","DOI":"10.1016\/j.clinimag.2016.10.015"},{"issue":"12","key":"444_CR24","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s003300100853","volume":"11","author":"VD Raptopoulos","year":"2001","unstructured":"Raptopoulos VD, Blake SP, Weisinger K, Atkins MB, Keogan MT, Kruskal JB. Multiphase contrast-enhanced helical CT of liver metastases from renal cell carcinoma. Eur Radiol. 2001;11(12):2504\u20139. https:\/\/doi.org\/10.1007\/s003300100853.","journal-title":"Eur Radiol"},{"issue":"4","key":"444_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jacr.2013.08.003","volume":"11","author":"DP Blagev","year":"2014","unstructured":"Blagev DP, Lloyd JF, Conner K, et al. Follow-up of incidental pulmonary nodules and the radiology report. J Am Coll Radiol. 2014;11(4):378\u201383. https:\/\/doi.org\/10.1016\/j.jacr.2013.08.003.","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"444_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2214\/AJR.18.19645","volume":"210","author":"M Price","year":"2018","unstructured":"Price M, Wu CC, Genshaft S, et al. Imaging and Management of Intrathoracic Renal Cell Carcinoma Metastases. AJR Am J Roentgenol. 2018;210(6):1181\u201391. https:\/\/doi.org\/10.2214\/AJR.18.19645.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"444_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2214\/AJR.09.2941","volume":"194","author":"AD Smith","year":"2010","unstructured":"Smith AD, Lieber ML, Shah SN. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: Importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol. 2010;194(1):157\u201365. https:\/\/doi.org\/10.2214\/AJR.09.2941.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"444_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.14132702","volume":"273","author":"Y Thian","year":"2014","unstructured":"Thian Y, Gutzeit A, Koh D-M, et al. Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib. Radiology. 2014;273(2):452\u201361. https:\/\/doi.org\/10.1148\/radiol.14132702.","journal-title":"Radiology"},{"key":"444_CR29","doi-asserted-by":"publisher","unstructured":"Schwartz LH, Liti\u00e8re S, Vries E de, et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016;62:132\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081.","DOI":"10.1016\/j.ejca.2016.03.081"},{"issue":"10189","key":"444_CR30","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/S0140-6736(19)30723-8","volume":"393","author":"BI Rini","year":"2019","unstructured":"Rini BI, Powles T, Atkins MB, et al. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. The Lancet. 2019;393(10189):2404\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(19)30723-8.","journal-title":"The Lancet"},{"issue":"5","key":"444_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1803675","volume":"379","author":"A M\u00e9jean","year":"2018","unstructured":"M\u00e9jean A, Ravaud A, Thezenas S, et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018;379(5):417\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1803675.","journal-title":"N Engl J Med"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-022-00444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-022-00444-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-022-00444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:33:07Z","timestamp":1642761187000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-022-00444-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s40644-022-00444-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective data evaluation was approved by the institutional review board which was assigned the approval number 197\/2020BO2. Verbal and written informed consent were waived due to the retrospective nature of the study. Consent for publication was given by all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u2018Not applicable\u2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"\u2018Not applicable\u2019.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}